Professor Nicola Dalbeth

MBChB MD FRACP

Biography

Nicola Dalbeth is an academic rheumatologist who leads a clinical and laboratory programme of research in gout, an inflammatory arthritis of major significance to Aotearoa New Zealand.  Her work focuses on understanding the impact and mechanisms of disease in gout. 

She has been lead investigator in both commercial and investigator-initiated clinical trials in gout.  She is a founding member of the Counties Manukau District Health Board Māori Gout Action Group. She chairs the Atlas of Healthcare Variation Gout Expert Advisory Group, and Australia and New Zealand Gout Special Interest Forum. She was the Lead Clinical Advisor for the Gout Clinical Pathways (Greater Auckland Integrated Healthcare Network) and the national bpac Gout Treatment Guidelines.  She has served as an Expert Panel member on the American College of Rheumatology Gout Management Guidelines, and is a steering committee member for the OMERACT gout working group and the ACR/EULAR gout classification project.

Research | Current

Clinical research includes clinical trials, imaging studies (using plain radiographs, MRI and three-dimensional CT modeling) to analyze joint damage, studies to investigate the functional impact of gout, and validation of outcome measures in gout.  The laboratory work in the Auckland Bone and Joint Research Laboratory involves investigating the cellular and molecular mechanisms of inflammation and joint damage in gout.

Selected publications and creative works (Research Outputs)

  • Fogarty, F. A., Booth, R. J., Lee, A. C., Dalbeth, N., & Consedine, N. S. (2019). Mindfulness-Based Stress Reduction with Individuals Who Have Rheumatoid Arthritis: Evaluating Depression and Anxiety as Mediators of Change in Disease Activity. MINDFULNESS, 10 (7), 1328-1338. 10.1007/s12671-018-1090-1
    Other University of Auckland co-authors: Arier Lee, Roger Booth, Nathan Consedine
  • Lu, J., Dalbeth, N., Yin, H., Li, C., Merriman, T. R., & Wei, W.-H. (2019). Mouse models for human hyperuricaemia: a critical review. NATURE REVIEWS RHEUMATOLOGY, 15 (7), 413-426. 10.1038/s41584-019-0222-x
  • Dalbeth, N., Frampton, C., Fung, M., Baumgartner, S., Nicolaou, S., & Choi, H. K. (2019). Concurrent validity of provisional remission criteria for gout: a dual-energy CT study. ARTHRITIS RESEARCH & THERAPY, 2110.1186/s13075-019-1941-8
  • Krasnoryadtseva, A., Dalbeth, N., & Petrie, K. (2019). Does seeing personal medical images change beliefs about illness and treatment in people with gout? A randomised controlled trial. PSYCHOLOGY & HEALTH10.1080/08870446.2019.1626396
    Other University of Auckland co-authors: Keith Petrie
  • Fatima, T., Nilsson, P., Turesson, C., Dehlin, M., Dalbeth, N., Jacobsson, L. T. H., & Kapetanovic, M. C. (2019). HOW DO GOUT-RELATED COMORBIDITIES AND LIFESTYLE FACTORS CLUSTER IN A LARGE HEALTH SURVEY OF THE GENERAL POPULATION? - RESULTS FROM THE MALMO PREVENTIVE PROJECT COHORT IN SOUTHERN SWEDEN. Paper presented at Annual European Congress of Rheumatology (EULAR), Madrid, SPAIN. 12 June - 15 June 2019. ANNALS OF THE RHEUMATIC DISEASES. (pp. 1). 10.1136/annrheumdis-2019-eular.5642
  • Fatima, T., Nilsson, P., Turesson, C., Dehlin, M., Dalbeth, N., Jacobsson, L. T. H., & Kapetanovic, M. C. (2019). THE ABSOLUTE RISK OF CLINICALLY DIAGNOSED GOUT BY CLUSTERS OF GOUT ASSOCIATED COMORBIDITIES AND LIFESTYLE FACTORS - RESULTS FROM 30 YEARS FOLLOW-UP OF THE MALMO PREVENTIVE PROJECT COHORT IN SOUTHERN SWEDEN. Paper presented at Annual European Congress of Rheumatology (EULAR), Madrid, SPAIN. 12 June - 15 June 2019. ANNALS OF THE RHEUMATIC DISEASES. (pp. 1). 10.1136/annrheumdis-2019-eular.5515
  • Stamp, L. K., Wright, D. F. B., & Dalbeth, N. (2019). Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!. British journal of clinical pharmacology, 85 (6), 1378-1379. 10.1111/bcp.13798
    URL: http://hdl.handle.net/2292/46223
  • Proudman, C., Lester, S. E., Gonzalez-Chica, D. A., Gill, T. K., Dalbeth, N., & Hill, C. L. (2019). Gout, flares, and allopurinol use: a population-based study. ARTHRITIS RESEARCH & THERAPY, 2110.1186/s13075-019-1918-7

Identifiers

Contact details

Primary office location

M&HS BUILDING 502 - Bldg 502
Level 2, Room 201D
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand

Web links